Concepedia

Erick Stanley Petersen Juárez

ES

Statistics

Publications

6

Citations

422

H-Index

6

Active since

2021

Affiliations

VIR Biotechnology (United States)(Current)

University of Washington

Fred Hutch Cancer Center

Florida International University

William Osler Health System

Erick Stanley Petersen Juárez is an author at VIR Biotechnology (United States) specializing in infectious diseases, pharmacotherapy, and sars-cov-2 infection.

Publications per year

2021–2024

6

Publications

6

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19

Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez et al. · JAMA · 2022 · 294 citations · Full text

, , +12

Early Covid-19 Treatment With SARS-CoV-2 Neutralizing Antibody Sotrovimab

Anil Kumar Gupta, Yaneicy Gonzalez‐Rojas, Erick Stanley Petersen Juárez et al. · medRxiv · 2021 · 53 citations · Full text

, , +16

Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial

Adrienne E. Shapiro, Elias Sarkis, Jude Acloque et al. · Open Forum Infectious Diseases · 2023 · 21 citations · Full text

, , +12

Bivalent RSVpreF Vaccine in Adults 18 to <60 Years Old With High-Risk Conditions

William Towner, Elliot DeHaan, Qin Jiang et al. · Clinical Infectious Diseases · 2024 · 21 citations · Full text

, , +17

502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Anil Kumar Gupta, Yaneicy Gonzalez Rojas, Erick Stanley Petersen Juárez et al. · Open Forum Infectious Diseases · 2021 · 17 citations · Full text

, , +15

1–5 of 6